Lynch syndrome testing in patients with colorectal cancer, CFTR testing in patients with suspected cystic fibrosis, Factor V Leiden or prothrombin gene testing in patients with thromboembolic disease. This evidence concerns the gene CFTR and Lynch syndrome.